![](/img/cover-not-exists.png)
Response to: âEfficacy and improved tolerability of combination therapy with interleukin-1 blockade and MAPK pathway inhibitors for the treatment of Erdheim-Chester diseaseâ by Campochiaro et al
Cohen-Aubart, Fleur, Benameur, Neila, Amoura, Zahir, Haroche, JulienJournal:
Annals of the Rheumatic Diseases
DOI:
10.1136/annrheumdis-2019-216755
Date:
January, 2020
File:
PDF, 184 KB
2020